Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults

Japanese Journal of Infectious Diseases

Volumn 60, Issue 5, 2007, Pages 280-283

  Oksuz, Sukru ^a   Sahin, Idris ^b   Yildirim, Mustafa ^b   Gulcan, Aynur ^b   Yavuz, Tevfik ^b   Kaya, Demet ^b   Koc, Ayse Nedret ^c  

^a Duzce Ataturk State Hospital   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE; PROTEINASE;

ADULT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KEFYR; CANDIDA TROPICALIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FECES ANALYSIS; FEMALE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MOUTH; NONHUMAN; NORMAL HUMAN; SKIN; UROGENITAL SYSTEM;

ADULT; CANDIDA; FECES; FEMALE; HUMANS; MALE; MOUTH; PEPTIDE HYDROLASES; PHOSPHOLIPASES; SKIN; UROGENITAL SYSTEM;

EID: 34948875353     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Calderone, A.-R. and Fonzi, W.-A. (2000): Virulence factors of Candida albicans. Trends Microbiol., 9, 327-335.
2. Naglik, J.-R., Newport, G., White, T.-C., et al. (1999): In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun., 67, 2482-2490.
3. Ghannoum, M.-A. (2000): Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev., 13, 122-143.
4. Julian, R., Naglik, J.-R., Challacombe, S.-J., et al. (2003): Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev., 67, 400-428.
5. Niewerth, M. and Korting, H.-C. (2001): Phospholipase of Candida albicans. Mycoses, 44, 361-367.
6. Hannula, J., Saarela, M., Dogan, B., et al. (2000): Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol. Immunol., 15, 238-244.
7. Larone, D.H. (1995): Medically Important Fungi, a Guide to Identification. 3rd ed. American Society for Microbiology, Washington, D.C.
8. Hazen, K.-C. and Howell, S.-A. (2003): Candida, cryptococcus and other yeasts of medical importance. p. 1693-1711. In P.P. Murray, E.J.O. Baron, M.A Pfaller., et al. (ed.), Manual of Clinical Microbiology. American Society for Microbiology, Washington, D.C.
9. Sullivan, D.-J., Westerneng, T.-J., Haynes, K.-A., et al. (1995): Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV infected individuals. Microbiology, 141, 1507-1521.
10. Polak, A. (1992): Virulence of Candida albicans mutants. Mycoses, 35, 9-16.
11. Price, M.-F., Wilkinson, I.-D. and Gentry, L.-O. (1982): Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia, 20, 7-14.
12. Aoki, S., Ito-Kuwa, S., Nakamura, Y., et al. (1990): Comparative pathogenicity of wild-type strains and respiratory mutants of Candida albicans in mice. Zentralbl. Bakteriol., 273, 332-343.
13. Dostal, J., Hamal, P., Pavlikova, L., et al. (2003): Simple method for screening Candida spp. isolates for the presence of secreted proteinases: a tool for the prediction of successful inhibitory treatment. J. Clin. Microbiol., 41, 712-716.
14. Xu, J. and Mitchell, T.-G. (2003): Geographical differences in human oral yeast flora. Clin. Infect. Dis., 36, 221-222.
15. Kantarcioglu, A.-S. and Yucel, A. (2002): Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses, 45, 160-165.
16. Giraldo, P., Nowaskonski, A.-V., Gomes, F.-A., et al. (2000): Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet. Gynecol., 95, 413-416.
17. Krzeminska-Jaskowiak, E., Cybulski, Z. and Pietkiewicz, K. (1995): Characterization of Candida spp. strains isolated from different clinical specimens in the years 1989-1993. Przegl. Epidemiol., 49, 305-311.
18. Samaranayake, L.-P., Raeside, J.-M. and Max Farlane, T.-W. (1984): Factors affecting the phospholipase activitiy of Candida spp. in vitro. Sabouraudia, 22, 201-207.
19. Ibrahim, A.-S., Mirbod, F., Filler, S.-G., et al. (1995): Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun., 63, 1993-1998.
20. Vidotto, V., Kogo-Ito, C.-Y., Milano, R., et al. (1999): Correlation between germ tube production, phospholipase activitiy and distribution and serotype in Candida albicans. Rev. Iberoam. Micol., 6, 208-210.
21. Al-Hedaithy, S.-S. (2002): Spectrum and proteinase production of yeasts causing vaginitis in Saudi Arabian women. Med. Sci. Monit, 8, 498-501.
22. Vidotto, V., Kogo-Ito, C.-Y., Garramone, A., et al. (1999): Virulence factors serotype distribution and adherence in Candida albicans. p. 219. Abstr. The 5th Congress of the European Confederation of Medical Mycology, Mycoses, Dresden, Germany.